Compare Nuwellis Inc (NUWE) vs Vanguard Intermediate Term Corporate Bond ETF (VCIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Vanguard Intermediate Term Corporate Bond ETF — how do they compare? Nuwellis Inc trades at $2.95 (market cap $1.09M), while Vanguard Intermediate Term Corporate Bond ETF trades at $81.54. Which is the better fit depends on your goals.
| NUWE | VCIT | |
|---|---|---|
Market Cap | $1.09M | — |
Sector | Technology | Fixed Income |
52-Week High | $527.46 | $84.82 |
52-Week Low | $2.80 | $81.45 |
Enterprise Value | -$722.58K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Vanguard Intermediate Term Corporate Bond ETF
VCIT tracks the Bloomberg U.S. 5-10 Year Corporate Bond Index, providing exposure to investment-grade debt from industrial, utility, and financial companies. It acts as a middle-ground bond fund, offering higher yields than short-term bonds with less price volatility than long-term corporate debt.
Read more on VCIT →
